Patent application number | Description | Published |
20140127156 | Hepatitis C Virus Inhibitors - Hepatitis C virus inhibitors having the general formula (I) | 05-08-2014 |
20140294898 | MACROCYCLIC INHIBITORS OF THE PD-1/PD-L1 AND CD80(B7-1)/PD-L1 PROTEIN/PROTEIN INTERACTIONS - The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases. | 10-02-2014 |
20150125422 | Hepatitis C Virus Inhibitors - Hepatitis C virus inhibitors having the general formula (I) | 05-07-2015 |
20150274753 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C - The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV. | 10-01-2015 |
20150284391 | HEPATITIS C VIRUS INHIBITORS - Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed. | 10-08-2015 |
20150284409 | Hepatitis C Virus Inhibitors - Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed. | 10-08-2015 |
20150329547 | Hepatitis C Virus Inhibitors - Hepatitis C virus inhibitors having the general formula (I) | 11-19-2015 |
20160102122 | Immunomodulators - The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases. | 04-14-2016 |